KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Labcorp Holdings (LH) EBT Margin (2016 - 2025)

Labcorp Holdings (LH) has disclosed EBT Margin for 17 consecutive years, with 5.42% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 10.0% to 5.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.94% through Dec 2025, up 56.0% year-over-year, with the annual reading at 7.94% for FY2025, 56.0% up from the prior year.
  • EBT Margin hit 5.42% in Q4 2025 for Labcorp Holdings, down from 9.46% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 41.73% in Q4 2021 to a low of 4.85% in Q4 2023.
  • Historically, EBT Margin has averaged 11.11% across 5 years, with a median of 8.8% in 2023.
  • Biggest five-year swings in EBT Margin: surged 3403bps in 2021 and later tumbled -4138bps in 2022.
  • Year by year, EBT Margin stood at 41.73% in 2021, then tumbled by -99bps to 0.35% in 2022, then plummeted by -1493bps to 4.85% in 2023, then soared by 214bps to 5.52% in 2024, then dropped by -2bps to 5.42% in 2025.
  • Business Quant data shows EBT Margin for LH at 5.42% in Q4 2025, 9.46% in Q3 2025, and 8.64% in Q2 2025.